HPV Vaccine Hesitancy Among Female Students in China Increases Despite Improved Knowledge
HPV vaccine hesitancy among female university students in China rose from 8.8% to 21.6% between 2022 and 2025, despite improved knowledge.
Asset
HPV
Indication
Signal assessment
Signal strength
high
Confidence level
high
Why it matters
The significant rise in HPV vaccine hesitancy among female university students in China poses a serious challenge to public health and market growth for HPV vaccines. This trend indicates a need for pharma companies to reassess their marketing and educational strategies to effectively address the underlying factors contributing to this hesitancy.
Recommended action
Humanexa recommends Investigate.
Analysis
Monitor changes in public health campaigns and vaccine uptake rates, as well as any new initiatives targeting vaccine hesitancy.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.